Evidence map›Paper›PMID 38019994›Full record

ArticleRSC advances2023

Structural modulation of insulin by hydrophobic and hydrophilic molecules.

Shahnaz Begum, Hasan Parvej, Ramkrishna Dalui, Swarnali Paul, Sanhita Maity, Nayim Sepay, Mohd Afzal, Umesh Chandra Halder

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Assessment ofMolecular pharmaceutics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Shahnaz BegumDepartment of Chemistry, Jadavpur University Kolkata-700032 India juumesh.halder@gmail.com.ORCID https://orcid.org/0009-0008-1742-7947
Hasan ParvejDepartment of Chemistry, Jadavpur University Kolkata-700032 India juumesh.halder@gmail.com.ORCID https://orcid.org/0000-0002-0443-5920
Ramkrishna DaluiDepartment of Chemistry, Jadavpur University Kolkata-700032 India juumesh.halder@gmail.com.
Swarnali PaulDepartment of Chemistry, Jadavpur University Kolkata-700032 India juumesh.halder@gmail.com.
Sanhita MaityDepartment of Chemistry, Jadavpur University Kolkata-700032 India juumesh.halder@gmail.com.
Nayim SepayDepartment of Chemistry, Lady Brabourne College Kolkata-700017 India.ORCID https://orcid.org/0000-0001-7702-3989
Mohd AfzalDepartment of Chemistry, College of Science, King Saud University Riyadh 11451 Saudi Arabia.
Umesh Chandra HalderDepartment of Chemistry, Jadavpur University Kolkata-700032 India juumesh.halder@gmail.com.ORCID https://orcid.org/0000-0002-1715-3869
Jadavpur University · INKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the bloodstream, insulin interacts with various kinds of molecules, which can alter its structure and modulate its function. In this work, we have synthesized two molecules having extremely hydrophilic and hydrophobic side chains. The effects of hydrophilic and hydrophobic molecules on the binding with insulin have been investigated through a multi-spectroscopic approach. We found that hydrophilic molecules have a slightly higher binding affinity towards insulin. Insulin can bind with the hydrophilic molecules as it binds glucose. The high insulin binding affinity of a hydrophobic molecule indicates its dual nature. The hydrophobic molecule binds at the hydrophobic pocket of the insulin surface, where hydrophilic molecules interact at the polar surface of the insulin. Such binding with the hydrophobic molecule perturbs strongly the secondary structure of the insulin much more in comparison to hydrophilic molecules. Therefore, the stability of insulin decreases in the presence of hydrophobic molecules.

Identifiers

PMID38019994
PMCPMC10662218
OpenAlexW4388876998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.